leisure time -WSS

leisure time

author：hotspot 2025-09-03 14:37:22 - browse：366

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Raw milk easy to obtain despite bird flu warning, FDA interstate ban

hotspot

WSS

Free medical tuition alone isn't enough to close gaps in primary care

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

CVS is willing to dump 10% of its Medicare Advantage members

ALS treatment from Biogen, Ionis fails in study

STAT series 'Denied by AI' wins major journalism prizes

leisure time

leisure time

knowledge

Virginia high school admissions case could be legal follow

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Medicare proposal to cover medical devices draws a mixed reaction

STAT series 'Denied by AI' wins major journalism prizes

As demand for Covid shots wanes, Moderna seeks its next success

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

How to save PrEP access — and even expand it

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Virginia high school admissions case could be legal follow

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

hotspot

The United States must get value

Fertility clinic egg and embryo storage is a disaster

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Care demand spikes challenge UnitedHealth’s provider arm

Who gets to use the title 'doctor'?

Oak Street deal isn't the answer to health care's woes

focus

hotspot

hotspot

explore